Literature DB >> 4108890

Clinical experience with ethambutol.

T M Wilson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4108890     DOI： 10.1159/000386824

Source DB:  PubMed          Journal:  Antibiot Chemother


× No keyword cloud information.
  6 in total

1.  Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis.

Authors:  K Takayama; J O Kilburn
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  Peripheral neuropathy with ethambutol.

Authors:  P Tugwell; S L James
Journal:  Postgrad Med J       Date:  1972-11       Impact factor: 2.401

Review 3.  Antimicrobial agent resistance in mycobacteria: molecular genetic insights.

Authors:  J M Musser
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

4.  A single point mutation in the embB gene is responsible for resistance to ethambutol in Mycobacterium smegmatis.

Authors:  M A Lety; S Nair; P Berche; V Escuyer
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

5.  Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis.

Authors:  K Takayama; E L Armstrong; K A Kunugi; J O Kilburn
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

6.  Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope.

Authors:  L Deng; K Mikusová; K G Robuck; M Scherman; P J Brennan; M R McNeil
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.